Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique. / Hogh, B; Thompson, R; Hetzel, C; Fleck, S L; Kruse, N A; Jones, I; Dgedge, M; Barreto, J; Sinden, R E.

In: American Journal of Tropical Medicine and Hygiene, Vol. 52, No. 1, 01.1995, p. 50-9.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hogh, B, Thompson, R, Hetzel, C, Fleck, SL, Kruse, NA, Jones, I, Dgedge, M, Barreto, J & Sinden, RE 1995, 'Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique', American Journal of Tropical Medicine and Hygiene, vol. 52, no. 1, pp. 50-9.

APA

Hogh, B., Thompson, R., Hetzel, C., Fleck, S. L., Kruse, N. A., Jones, I., Dgedge, M., Barreto, J., & Sinden, R. E. (1995). Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique. American Journal of Tropical Medicine and Hygiene, 52(1), 50-9.

Vancouver

Hogh B, Thompson R, Hetzel C, Fleck SL, Kruse NA, Jones I et al. Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique. American Journal of Tropical Medicine and Hygiene. 1995 Jan;52(1):50-9.

Author

Hogh, B ; Thompson, R ; Hetzel, C ; Fleck, S L ; Kruse, N A ; Jones, I ; Dgedge, M ; Barreto, J ; Sinden, R E. / Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique. In: American Journal of Tropical Medicine and Hygiene. 1995 ; Vol. 52, No. 1. pp. 50-9.

Bibtex

@article{09f658e6c2fa4afba3a924332ad03b50,
title = "Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique",
abstract = "We have observed specific and nonspecific reactivities to the asexual states and gametocytes of Plasmodium falciparum and examined the effect of chloroquine and Fansidar (pyrimethamine/sulfadoxine) on the dynamics of gametocytemia. Schoolchildren peripheral blood films positive for P. falciparum gametocytes were identified in a malaria-endemic area of Mozambique. The children were randomly allocated into two groups to receive chloroquine or pyrimethamine/sulfadoxine, and were followed for 28 days after treatment. In patients harboring drug-sensitive parasites, asexual parasitemias were cleared by day 4, but gametocytes persisted for an additional 17 days. The prevalence of the asexual parasites was 67.6% in the chloroquine-treated group at day 0 and 61.1% at day 28, whereas in the pyrimethamine/sulfadoxine treated group, the initial parasite prevalence of 70.7% was reduced to 2.4% at day 28, suggesting a high prevalence of chloroquine-resistant parasites. On day 0, gametocyte prevalence was 59.5% in the chloroquine-treated group and in 68.3% in the pyrimethamine/sulfadoxine-treated group; these values were reduced to 5.6% and 2.4%, respectively, at day 28. Our results suggest strongly that there is no induction of gametocytogenesis by either course of chemotherapy.",
keywords = "Adolescent, Animals, Antibodies, Protozoan/blood, Antigens, Protozoan/immunology, Antimalarials/pharmacology, Blotting, Western, C-Reactive Protein/analysis, Child, Chloroquine/pharmacology, Computer Simulation, Drug Combinations, Drug Resistance, Enzyme-Linked Immunosorbent Assay, Fluorescent Antibody Technique, Haptoglobins/analysis, Humans, Luminescent Measurements, Malaria, Falciparum/drug therapy, Models, Biological, Mozambique/epidemiology, Parasitemia/drug therapy, Plasmodium falciparum/drug effects, Prevalence, Pyrimethamine/pharmacology, Recombinant Proteins/immunology, Sulfadoxine/pharmacology",
author = "B Hogh and R Thompson and C Hetzel and Fleck, {S L} and Kruse, {N A} and I Jones and M Dgedge and J Barreto and Sinden, {R E}",
year = "1995",
month = jan,
language = "English",
volume = "52",
pages = "50--9",
journal = "Journal. National Malaria Society",
issn = "0002-9637",
publisher = "American Society of Tropical Medicine and Hygiene",
number = "1",

}

RIS

TY - JOUR

T1 - Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique

AU - Hogh, B

AU - Thompson, R

AU - Hetzel, C

AU - Fleck, S L

AU - Kruse, N A

AU - Jones, I

AU - Dgedge, M

AU - Barreto, J

AU - Sinden, R E

PY - 1995/1

Y1 - 1995/1

N2 - We have observed specific and nonspecific reactivities to the asexual states and gametocytes of Plasmodium falciparum and examined the effect of chloroquine and Fansidar (pyrimethamine/sulfadoxine) on the dynamics of gametocytemia. Schoolchildren peripheral blood films positive for P. falciparum gametocytes were identified in a malaria-endemic area of Mozambique. The children were randomly allocated into two groups to receive chloroquine or pyrimethamine/sulfadoxine, and were followed for 28 days after treatment. In patients harboring drug-sensitive parasites, asexual parasitemias were cleared by day 4, but gametocytes persisted for an additional 17 days. The prevalence of the asexual parasites was 67.6% in the chloroquine-treated group at day 0 and 61.1% at day 28, whereas in the pyrimethamine/sulfadoxine treated group, the initial parasite prevalence of 70.7% was reduced to 2.4% at day 28, suggesting a high prevalence of chloroquine-resistant parasites. On day 0, gametocyte prevalence was 59.5% in the chloroquine-treated group and in 68.3% in the pyrimethamine/sulfadoxine-treated group; these values were reduced to 5.6% and 2.4%, respectively, at day 28. Our results suggest strongly that there is no induction of gametocytogenesis by either course of chemotherapy.

AB - We have observed specific and nonspecific reactivities to the asexual states and gametocytes of Plasmodium falciparum and examined the effect of chloroquine and Fansidar (pyrimethamine/sulfadoxine) on the dynamics of gametocytemia. Schoolchildren peripheral blood films positive for P. falciparum gametocytes were identified in a malaria-endemic area of Mozambique. The children were randomly allocated into two groups to receive chloroquine or pyrimethamine/sulfadoxine, and were followed for 28 days after treatment. In patients harboring drug-sensitive parasites, asexual parasitemias were cleared by day 4, but gametocytes persisted for an additional 17 days. The prevalence of the asexual parasites was 67.6% in the chloroquine-treated group at day 0 and 61.1% at day 28, whereas in the pyrimethamine/sulfadoxine treated group, the initial parasite prevalence of 70.7% was reduced to 2.4% at day 28, suggesting a high prevalence of chloroquine-resistant parasites. On day 0, gametocyte prevalence was 59.5% in the chloroquine-treated group and in 68.3% in the pyrimethamine/sulfadoxine-treated group; these values were reduced to 5.6% and 2.4%, respectively, at day 28. Our results suggest strongly that there is no induction of gametocytogenesis by either course of chemotherapy.

KW - Adolescent

KW - Animals

KW - Antibodies, Protozoan/blood

KW - Antigens, Protozoan/immunology

KW - Antimalarials/pharmacology

KW - Blotting, Western

KW - C-Reactive Protein/analysis

KW - Child

KW - Chloroquine/pharmacology

KW - Computer Simulation

KW - Drug Combinations

KW - Drug Resistance

KW - Enzyme-Linked Immunosorbent Assay

KW - Fluorescent Antibody Technique

KW - Haptoglobins/analysis

KW - Humans

KW - Luminescent Measurements

KW - Malaria, Falciparum/drug therapy

KW - Models, Biological

KW - Mozambique/epidemiology

KW - Parasitemia/drug therapy

KW - Plasmodium falciparum/drug effects

KW - Prevalence

KW - Pyrimethamine/pharmacology

KW - Recombinant Proteins/immunology

KW - Sulfadoxine/pharmacology

M3 - Journal article

C2 - 7856825

VL - 52

SP - 50

EP - 59

JO - Journal. National Malaria Society

JF - Journal. National Malaria Society

SN - 0002-9637

IS - 1

ER -

ID: 203011340